 |
市场调查报告书
商品编码
1190079
生物材料伤口敷料市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)Biomaterial Wound Dressing Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在预测期内，生物材料伤口敷料市场的复合年增长率预计为 11.2%。
COVID-19 大流行严重影响了医疗保健行业，包括生物材料伤口敷料部分。 此外，COVID-19 大流行影响了全球经济，也对全球医院为非 COVID-19 患者提供的综合医院护理的运作产生了重大影响。 例如，AJMC 于 2021 年 9 月发表的一篇论文发现，在 COVID-19 流行期间，相当一部分慢性伤口患者延迟了预防性和紧急伤口护理。我在这里。 COVID-19 大流行期间的此类延误对所研究市场的增长产生了负面影响。 然而，解除限制有望重启伤口治疗服务，在预测期内刺激生物材料伤口敷料市场的增长。
生物材料伤口敷料市场受到技术进步、人口老龄化、慢性伤口和问题负担增加以及与传统伤口癒合治疗相关的副作用的推动。 此外，政府举措的增加、对慢性伤口迅速和安全治疗的需求、生活方式障碍的流行，如导致静脉性腿部溃疡、压力性溃疡和糖尿病性腿部溃疡的糖尿病，都在推动市场增长。 例如，根据国际糖尿病联合会的 IDF 糖尿病地图集第十版 2021，2021 年全球有超过 5.37 亿成年人患有糖尿病。 同一份文件还报告说，全球糖尿病患者人数到 2030 年将增加到 6.43 亿，到 2045 年将增加到 7.83 亿。 预计容易患足部溃疡的糖尿病患者数量增加将促进研究市场的增长。
致力于伤口管理的公共卫生项目的扩展也有望刺激市场增长。 例如，在 2022 年 5 月由国家伤口护理战略计划主办的网络研讨会上，主持人讨论了许多不同的治疗腿部静脉溃疡的方法。 预期市场的扩大将受益于旨在提高公众对伤口护理服务意识的举措。
然而，高昂的治疗费用和不利的报销政策是阻碍市场增长的一些因素。
主要市场趋势
海藻酸盐涂料预计在预测期内占很大份额
藻酸盐敷料是一种轻质无纺布天然伤口敷料，由可促进癒合的高吸水性材料製成。 广泛用于液体过多的创伤。 藻酸盐敷料通常由种子树製成，因此具有很强的吸收性，可以提供适合治疗干燥伤口的湿润伤口环境。
此外，藻酸盐敷料适用于治疗流血的伤口，并通过保持神经末梢湿润来减轻疼痛。 因此，它适用于治疗大量出血的伤口、手术伤口、一度和二度烧伤以及供体部位，并可能在预测期内推动该领域的增长。
由于其亲水性，海藻酸被广泛用于伤口癒合。 例如，2021 年 9 月发表在 Personalized Medicine 上的一篇论文表明，与其他生物材料相比，藻酸盐是最常见的具有伤口癒合特性的生物材料。 藻酸盐伤口敷料因其亲水性而广泛应用于珠子、混合物、敷料、电纺支架、柔性纤维、薄膜、泡沫、凝胶、水凝胶、注射剂、微粒、微球、纳米粒子、聚电解质复合材料。 、粉末、绳索、床单和海绵，用于创伤后和渗出的伤口。 海藻酸盐敷料的广泛应用有望在预测期内促进研究领域的增长。
此外，近年来关于使用藻酸盐敷料治疗慢性伤口癒合的研究不断增加。 例如，2021 年 6 月发表在 F1000Res. 上的一篇论文表明，含有没食子酸的藻酸盐生物膜可有效用于治疗具有低度至中度脓液的慢性伤口。 因此，在预测期内，改进对藻酸盐敷料的研究有望推动该细分市场的增长。
预计在预测期内北美将占据很大的市场份额
北美生物材料伤口敷料市场预计将在全球占有重要的市场份额。 推动该地区市场的主要因素是适应快速老龄化社会的先进医疗体系、高糖尿病人口和创新。
糖尿病患者人数的增加是市场增长的主要推动力。 例如，根据 2022 年 1 月更新的全国糖尿病统计报告，美国约有 3730 万人患有糖尿病，约占总人口的 11.3%。 另据报导，美国约有 9600 万 18 岁及以上的人处于糖尿病前期。 此外，根据美国糖尿病协会 2022 年 2 月更新的统计数据，美国估计有 283,000 名 20 岁以下的人被诊断患有糖尿病，约占其中的 35%。
此外，根据国际糖尿病联合会的数据，到 2021 年，加拿大将有超过 290 万年龄在 20 至 79 岁之间的人患有糖尿病。 数据指出，到2040年，日本糖尿病患者人数将增至约350万。 在北美地区，预计容易患足部溃疡的糖尿病患者人数会增加，从而增加对创新伤口敷料技术的需求，预计这将在预测期内刺激市场增长。
此外，主要市场参与者的存在及其在新产品发布和研发方面的活动预计将推动该地区的市场增长。
竞争格局
生物材料伤口敷料市场是一个高度分散且竞争激烈的市场。 3M、ConvaTec Group PLC、Molnlycke Health Care AB、Smith & Nephew PLC 和 B. Braun Melsungen AG 等主要市场参与者在该行业中占有重要份额。 大多数市场参与者都专注于将先进的产品推向市场以获取最大的市场份额。
其他福利。
- Excel 格式的市场预测 (ME) 表
- 三个月的分析师支持
内容
第一章介绍
- 研究假设和市场定义
- 调查范围
第二章研究方法论
第 3 章执行摘要
第四章市场动态
- 市场概览
- 市场驱动力
- 增加慢性伤口和相关疾病的负担
- 伤口护理方面的政府举措
- 市场製约因素
- 缺乏适当的报销
- 波特的五力分析
- 新进入者的威胁
- 买方/消费者议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争公司之间的敌对关係
第五章市场细分（价值基础，单位：百万美元）
- 按产品分类
- 水胶体
- 海藻酸覆盖材料
- 皮肤替代品
- 其他产品
- 通过使用
- 伤口
- 伯恩斯
- 溃疡
- 其他用途
- 按地区
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 意大利
- 西班牙
- 其他欧洲地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东和非洲
- 海湾合作委员会
- 南非
- 其他中东和非洲地区
- 南美洲地区
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第六章竞争格局
- 公司简介
- 3M
- ConvaTec Group PLC
- DermaRite Industries LLC
- B. Braun Melsungen AG
- Hollister Incorporated
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Medtronic PLC
- Molnlycke Health Care AB
- Smith & Nephew PLC
第7章 市场机会与今后动向
The biomaterial wound dressing market is expected to register a CAGR of 11.2% during the forecast period.
The COVID-19 pandemic severely affected the healthcare sector, including the biomaterial wound dressing segment. Moreover, the COVID-19 pandemic affected the global economy and showed a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals globally. For instance, according to an article published by the AJMC in September 2021, a significant percentage of patients with chronic wounds had delayed preventative and emergent wound care during the COVID-19 pandemic. Such delays during the COVID-19 pandemic negatively impacted the growth of the studied market. However, with the restrictions being lifted, wound care services have been resumed, which is expected to add to the growth of the biomaterial wound dressing market over the forecast period.
The biomaterial wound dressing market is driven by advancements in technology, a growing ageing population, the rising burden of chronic wounds and problems, and side effects associated with conventional wound healing procedures. Furthermore, an increase in government initiatives, demand for fast and safe treatment for chronic wounds, and an increase in the prevalence of lifestyle disorders such as diabetes leading to venous leg ulcers, pressure ulcers, and diabetic foot ulcers propels the growth of the market. For instance, according to the International Diabetes Federation's IDF Diabetes Atlas Tenth edition 2021, over 537 million adults in the world were living with diabetes in the year 2021. The source also reported that the number of diabetic people in the world would increase to 643 million by 2030 and 783 million by 2045. The rising number of people affected by diabetes, who are more susceptible to foot ulcers is expected to boost the growth of the studied market.
The expansion of public health programs devoted to wound management is also anticipated to fuel market expansion. During a webinar hosted by the National Wound Care Strategy Programme in May 2022, for instance, presenters discussed a number of different approaches to healing venous leg ulcers. The expansion of the examined market is anticipated to benefit from initiatives aimed at raising public awareness of wound care services.
However, the high cost of treatment and unfavorable reimbursement policies are the few factors that hinder the market growth.
Key Market Trends
Alginate Dressing is Anticipated Have Significant Share in the Forecast Period
Alginate dressing refers to light, non-woven natural wound dressings that are composed of highly absorbent materials and promote healing. These are widely used in exudent wounds, where there is excess fluid. Alginate dressing is usually made from seed wood thus, highly absorbent and providing a moist wound environment that is favorable for treating dry injuries.
Furthermore, alginate dressing is suitable to treat bleeding wounds and keep nerve endings moist reducing pain. This makes them preferable in treating heavily draining wounds, surgical wounds, first and second-degree burns, and in donor sites, this is likely to fuel the segment growth over the forecast period.
Alginate is widely used in wound healing properties owing to its hydrophilic nature. For instance, according to an article published in the journal of Personalized Medicine in September 2021, alginate is the most common biomaterial with wound-healing properties, when compared to other biomaterials. The alginate wound dressing can take up multiple forms such as beads, blends, dressings, electrospun scaffolds, flexible fibers, films, foams, gels, hydrogels, injections, microparticles, microspheres, nanoparticles, polyelectrolyte complex, powders, ropes, sheets, sponges, and others due to its hydrophilic nature, and are thus used on post-traumatic wounds or exuding wounds. Such wide application of the alginate dressing is expected to boost the growth of the studied segment over the forecast period.
Moreover, the research on the use of alginate dressing for chronic wound healing has also been on the rise in recent years. For example, an article published in F1000Res. in June 2021 indicated that gallic acid-incorporated alginate biofilm could be efficiently used for the treatment of low to medium-suppurating chronic wounds. Thus, the improved research on alginate dressings is expected to propel the growth of the market segment over the forecast period.
North America Expected to have Significant Market Share in the Forecast Period
North America's biomaterial wound dressing market is projected to have a significant market share worldwide. Major factors that are driving the market in the region are a rapidly growing aging population, a high diabetic population, and the developed healthcare system, which adapts to novel innovations.
The increasing number of people affected by diabetes is a major factor contributing to the market growth. For instance, according to the National Diabetes Statistics Report updated in January 2022, around 37.3 million people in United States have diabetes, which equates to around 11.3% of the total population. Also, the report stated that around 96 million people aged 18 years or older in United States have prediabetes. Moreover, as per the American Diabetes Association Statistics updated in February 2022, about 283,000 people in United States under the age of 20 are estimated to have been diagnosed with diabetes, approximately 35% of that population.
Also, as per the International Diabetes Federation, in 2021, over 2.9 million people in Canada in the age group of 20-79 years were found to be affected by diabetes. The same source indicated that by 2040, the number of people with diabetes in the nation would rise up to around 3.5 million. The rising diabetic population in the North American region, who are more susceptible to foot ulcers, is expected to increase the demand for innovative wound dressing technologies, which is likely to add to the market growth over the forecast period.
Moreover, the presence of key market players coupled with their activity in the launching of new products and R&D are expected to bolster the market growth in the region.
Competitive Landscape
The biomaterial wound dressing market is moderately fragmented and competitive. The major market players, such as 3M, ConvaTec Group PLC, Molnlycke Health Care AB, Smith & Nephew PLC, and B. Braun Melsungen AG, hold a significant market share in the industry. Most of the market players are focusing on bringing advanced products in the market to acquire the maximum market share.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Growing Burden of Chronic Wounds and Associated Diseases
- 4.2.2 Government Initiatives Regarding Wound Care Treatment
- 4.3 Market Restraints
- 4.3.1 Lack of Proper Reimbursement
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - in USD Millions)
- 5.1 By Product
- 5.1.1 Hydrocolloids
- 5.1.2 Alginate Dressing
- 5.1.3 Skin Substitutes
- 5.1.4 Other Products
- 5.2 By Application
- 5.2.1 Wounds
- 5.2.2 Burns
- 5.2.3 Ulcers
- 5.2.4 Other Applications
- 5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle-East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle-East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
- 5.3.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 3M
- 6.1.2 ConvaTec Group PLC
- 6.1.3 DermaRite Industries LLC
- 6.1.4 B. Braun Melsungen AG
- 6.1.5 Hollister Incorporated
- 6.1.6 Integra LifeSciences Holdings Corporation
- 6.1.7 Johnson & Johnson
- 6.1.8 Medtronic PLC
- 6.1.9 Molnlycke Health Care AB
- 6.1.10 Smith & Nephew PLC
